146 related articles for article (PubMed ID: 38568780)
1. Stressing the Role of CCL3 in Reversing the Immunosuppressive Microenvironment in Gliomas.
Cui X; Kang C
Cancer Immunol Res; 2024 May; 12(5):514. PubMed ID: 38568780
[TBL] [Abstract][Full Text] [Related]
2. Chronic Stress Exacerbates the Immunosuppressive Microenvironment and Progression of Gliomas by Reducing Secretion of CCL3.
Wang X; Zhang L; Zhou Y; Wang Y; Wang X; Zhang Y; Quan A; Mao Y; Zhang Y; Qi J; Ren Z; Gu L; Yu R; Zhou X
Cancer Immunol Res; 2024 May; 12(5):516-529. PubMed ID: 38437646
[TBL] [Abstract][Full Text] [Related]
3. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
4. Predominance of M2 macrophages in gliomas leads to the suppression of local and systemic immunity.
Vidyarthi A; Agnihotri T; Khan N; Singh S; Tewari MK; Radotra BD; Chatterjee D; Agrewala JN
Cancer Immunol Immunother; 2019 Dec; 68(12):1995-2004. PubMed ID: 31690954
[TBL] [Abstract][Full Text] [Related]
5. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
[TBL] [Abstract][Full Text] [Related]
6. Immunological classification of gliomas based on immunogenomic profiling.
Feng Q; Li L; Li M; Wang X
J Neuroinflammation; 2020 Nov; 17(1):360. PubMed ID: 33246490
[TBL] [Abstract][Full Text] [Related]
7. Molecular interactions between tumor and its microenvironment in malignant gliomas.
Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
[TBL] [Abstract][Full Text] [Related]
8. The CXCL Family Contributes to Immunosuppressive Microenvironment in Gliomas and Assists in Gliomas Chemotherapy.
Wang Z; Liu Y; Mo Y; Zhang H; Dai Z; Zhang X; Ye W; Cao H; Liu Z; Cheng Q
Front Immunol; 2021; 12():731751. PubMed ID: 34603309
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment
Zha C; Meng X; Li L; Mi S; Qian D; Li Z; Wu P; Hu S; Zhao S; Cai J; Liu Y
Cancer Biol Med; 2020 Feb; 17(1):154-168. PubMed ID: 32296583
[No Abstract] [Full Text] [Related]
10. [The immunosuppressive microenvironment of malignant gliomas].
Borisov KE; Sakaeva DD
Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
[TBL] [Abstract][Full Text] [Related]
11. Immune microenvironment of gliomas.
Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of microenvironment characteristics and metabolic activity in glioma via multiphoton microscopy.
Fang N; Wu Z; Wang X; Lin Y; Li L; Huang Z; Chen Y; Zheng X; Cai S; Tu H; Kang D; Chen J
J Biophotonics; 2019 Oct; 12(10):e201900136. PubMed ID: 31251837
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment.
Xu Y; Zhang H; Sun Q; Geng R; Yuan F; Liu B; Chen Q
Front Immunol; 2021; 12():730289. PubMed ID: 34659216
[TBL] [Abstract][Full Text] [Related]
14. Generation and immunologic functions of Th17 cells in malignant gliomas.
Paladugu M; Thakur A; Lum LG; Mittal S; Parajuli P
Cancer Immunol Immunother; 2013 Jan; 62(1):75-86. PubMed ID: 22752645
[TBL] [Abstract][Full Text] [Related]
15. T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.
Kwok D; Okada H
J Neurooncol; 2020 Apr; 147(2):281-295. PubMed ID: 32185647
[TBL] [Abstract][Full Text] [Related]
16. Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.
Zhou W; Jiang Z; Li X; Xu Y; Shao Z
J Cancer Res Clin Oncol; 2015 Apr; 141(4):575-89. PubMed ID: 25005789
[TBL] [Abstract][Full Text] [Related]
17. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
18. Cytokine networks in glioma.
Iwami K; Natsume A; Wakabayashi T
Neurosurg Rev; 2011 Jul; 34(3):253-63; discussion 263-4. PubMed ID: 21656131
[TBL] [Abstract][Full Text] [Related]
19. CCL3 Signaling in the Tumor Microenvironment.
Ntanasis-Stathopoulos I; Fotiou D; Terpos E
Adv Exp Med Biol; 2020; 1231():13-21. PubMed ID: 32060842
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Value of EMT in Glioma and its Role in the Glioma Immune Microenvironment.
Ning W; Qiu Z; Ji X; Wang X; An Y; Wang S; Zhang H
J Mol Neurosci; 2020 Oct; 70(10):1501-1511. PubMed ID: 32495005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
